Physician profile
David A Dalessandro
NPI 1922188580
$76,823.43
in general payments reported to CMS, 2019-2025
10 companies · $2,943 in 2025
The $2,943 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,631 · 2020: $552 · 2021: $7,224 · 2022: $17K · 2023: $40K · 2024: $4,230 · 2025: $2,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $38K · Travel and Lodging: $3,879 · Food and Beverage: $3,524 · Consulting Fee: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $37,800.00 |
| Travel and Lodging | $3,879.09 |
| Food and Beverage | $3,523.72 |
| Consulting Fee | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $69,761.14 | 2019-2025 | Impella |
| Paragonix Technologies, INC. | $2,098.53 | 2022-2025 | Sherpapak, Liverguard, Pancreaspak |
| Abbott Laboratories | $1,125.34 | 2019-2024 | Epic, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Medtronic Vascular, INC. | $1,036.83 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,004.32 | 2021-2025 | Konect Resilia |
| Atricure, INC. | $830.81 | 2019-2024 | |
| Medtronic, INC. | $527.46 | 2024-2025 | Avalus, Penditure |
| Transmedics, INC. | $439.00 | 2023 | Organ Care System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dalessandro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.